The Enterprise Value as of December 2025 (TTM) for Steminent Biotherapeutics Inc. (7729.TWO) is 2.77B

According to Steminent Biotherapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.77B. This represents a change of 188.45% compared to the average of 961.34M of the last 4 quarters.

Steminent Biotherapeutics Inc. (7729.TWO) Historical Enterprise Value (quarterly & annually)

How has 7729.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Steminent Biotherapeutics Inc. over the last ten years is 1.41B. The current 2.77B Enterprise Value has changed 19.56% with respect to the historical average. Over the past ten years (40 quarters), 7729.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 1.75B. The Enterprise Value was at its lowest in in the December 2022 quarter at -98268000.00.

Steminent Biotherapeutics Inc. (7729.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Steminent Biotherapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Steminent Biotherapeutics Inc. (7729.TWO) Average Enterprise Value

How has 7729.TWO Enterprise Value performed in the past?

The current Enterprise Value of Steminent Biotherapeutics Inc. (7729.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Steminent Biotherapeutics Inc. (7729.TWO) Enterprise Value vs. Peers

How is 7729.TWO’s Enterprise Value compared to its peers?

Steminent Biotherapeutics Inc.’s Enterprise Value is greater than TaiRx, Inc. (2.42B), less than Gwo Xi Stem Cell Applied Technology Co. , Ltd (2.87B), greater than GlycoNex Incorporation (2.21B), less than Intech Biopharm Corporation (3.68B), greater than Taiwan Bio Therapeutics Co., Ltd (2.09B), greater than Anti-Microbial Savior BioteQ Co., Ltd (2.48B), greater than HeXun Biosciences Co., Ltd. (2.40B), greater than Hcmed (2.28B), greater than Sinew Pharma Inc. (2.76B), greater than Sunny Pharmtech Inc. (2.46B),

Build a custom stock screener for Steminent Biotherapeutics Inc. (7729.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Steminent Biotherapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Steminent Biotherapeutics Inc. (7729.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Steminent Biotherapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.